Shelter Pharma Ltd Stock Price Today (NSE: SHELTER)
Fundamental Score
Shelter Pharma Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shelter Pharma Ltd share price today is ₹29.00, down 0.03% on NSE/BSE as of 17 June 2026. Shelter Pharma Ltd (SHELTER) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹66.08 (Cr). The 52-week high for SHELTER share price is ₹50.00 and the 52-week low is ₹26.50. At a P/E ratio of 8.06x, SHELTER is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 18.44% and a debt-to-equity ratio of 0.02.
Shelter Pharma Ltd Share Price Chart — NSE/BSE Historical Performance
Shelter Pharma Ltd share price chart: -5.66% return over the past month. 52-week high ₹50.00, 52-week low ₹26.50.
Shelter Pharma Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹31.98 | ₹31.98 | ₹31.98 | ₹31.98 | 6.00K (Cr) | |
| ₹31.10 | ₹31.99 | ₹31.10 | ₹31.99 | 15.00K (Cr) | |
| ₹31.00 | ₹33.20 | ₹30.30 | ₹32.07 | 1.23L (Cr) | |
| ₹31.49 | ₹31.75 | ₹30.00 | ₹30.00 | 54.00K (Cr) | |
| ₹30.63 | ₹31.64 | ₹30.60 | ₹31.64 | 18.00K (Cr) | |
| ₹30.55 | ₹30.99 | ₹30.55 | ₹30.63 | 15.00K (Cr) | |
| ₹30.31 | ₹30.98 | ₹30.31 | ₹30.65 | 6.00K (Cr) | |
| ₹30.16 | ₹31.00 | ₹30.00 | ₹31.00 | 18.00K (Cr) | |
| ₹30.70 | ₹30.80 | ₹30.00 | ₹30.00 | 21.00K (Cr) | |
| ₹30.50 | ₹31.65 | ₹30.50 | ₹31.60 | 15.00K (Cr) |
Shelter Pharma Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹31.10 | ₹31.99 | ₹31.10 | ₹31.98 | +2.83% | |
| ₹30.99 | ₹33.70 | ₹28.51 | ₹32.07 | +3.48% | |
| ₹29.78 | ₹33.84 | ₹28.50 | ₹30.39 | +2.05% | |
| ₹35.00 | ₹35.00 | ₹26.50 | ₹26.83 | -23.34% | |
| ₹39.50 | ₹44.95 | ₹34.99 | ₹36.30 | -8.10% | |
| ₹36.56 | ₹43.60 | ₹30.21 | ₹40.80 | +11.60% | |
| ₹42.00 | ₹42.00 | ₹35.75 | ₹36.75 | -12.50% | |
| ₹41.73 | ₹46.51 | ₹39.50 | ₹41.99 | +0.62% | |
| ₹42.51 | ₹45.45 | ₹39.02 | ₹41.73 | -1.83% | |
| ₹46.20 | ₹46.98 | ₹42.00 | ₹44.57 | -3.53% | |
| ₹43.99 | ₹50.00 | ₹41.50 | ₹45.00 | +2.30% | |
| ₹44.92 | ₹47.00 | ₹40.80 | ₹43.99 | -2.07% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shelter Pharma Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shelter Pharma Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHELTER across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (18.44%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (24.48%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (16.87%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 8.06 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (27.12%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (38.36%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Excellent EPS Growth (28.87% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (146.22% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (92.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Negative Free Cash Flow (₹-0.35 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Shelter Pharma Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Shelter Pharma Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Shelter Pharma LtdShelter Pharma ...Selected✓ SHELTER • 543963 | 64.5/100 | ₹29.00₹29 | ₹66.08₹66.08 | 8.06Average 8.1 Average | 18.44%Good 18.44% Good | 24.48%Excellent 24.48% Excellent | 0.02Excellent 0.0 Excellent | 146.22%Excellent 146.22% Excellent | 10.99%Good 10.99% Good | 0.87% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Shelter Pharma Ltd PE Ratio History
Historical price-to-earnings ratio for SHELTER — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹5.36 | ₹55.79 | 10.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Shelter Pharma Ltd Dividend History
Annual cash dividends paid by SHELTER — dividend yield 0.87%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.38 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Shelter Pharma Ltd Quarterly Performance
Latest quarterly metrics for SHELTER — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
38.36%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
27.12%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
10.99%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
146.22%
Compounded annual net profit growth over 5 years
Shelter Pharma Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SHELTER — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Shelter Pharma Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Shelter Pharma Ltd (SHELTER) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Shelter Pharma Ltd
About SHELTER (Shelter Pharma Ltd)
Shelter Pharma Ltd is a long-standing Indian pharmaceutical company deeply rooted in the healthcare landscape since its establishment in 1965. From its base in Ahmedabad, the compa...ny operates with a commitment to providing a diverse range of pharmaceutical solutions for both human and animal health. Shelter Pharma actively formulates, manufactures, and distributes an array of products, solidifying its presence through a well-established distribution network that spans across India. The company’s enduring legacy reflects its dedication to meeting the evolving healthcare needs of the nation. The core of Shelter Pharma's business lies in its comprehensive portfolio of pharmaceutical products. For human healthcare, the company offers a spectrum of formulations, including tablets, capsules, syrups, and ointments, addressing a broad range of medical conditions. Additionally, they manufacture specialized oils tailored for therapeutic purposes. Complementing its human health offerings, Shelter Pharma caters to the veterinary sector with a mineral mixture designed to enhance animal health and nutrition. This dual focus allows the company to serve a wide customer base, promoting well-being across both human and animal populations. Shelter Pharma distributes its products strategically through an extensive network, ensuring accessibility and reach across the Indian market. They cater to both over-the-counter (OTC) and ethical pharmaceutical segments, showcasing its adaptability to diverse market demands. Furthermore, Shelter Pharma extends its reach beyond domestic borders through exports, further cementing its position as a significant player in the broader pharmaceutical industry. The company remains committed to innovation and quality, striving to deliver effective and reliable healthcare solutions that improve lives and contribute to a healthier future.
Company Details
Key Leadership
Corporate Events
Latest News
SHELTER Share Price: Frequently Asked Questions
What is the current share price of Shelter Pharma Ltd?
Shelter Pharma Ltd (SHELTER) trades at ₹29.00 on NSE and BSE. Market cap ₹66.08 (Cr). Educational data only.
What is the P/E ratio of Shelter Pharma Ltd?
Shelter Pharma Ltd has a P/E of 8.06x vs industry average 31.77x.
What is the Bull Run score for Shelter Pharma Ltd?
Shelter Pharma Ltd has a Bull Run score of 64.5/100 based on 25+ financial parameters.
Does Shelter Pharma Ltd pay dividends?
Shelter Pharma Ltd has a dividend yield of 0.87%. Past dividends don't guarantee future payments.
What is the ROE of Shelter Pharma Ltd?
Shelter Pharma Ltd has ROE of 18.44%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shelter Pharma Ltd?
Shelter Pharma Ltd has debt-to-equity of 0.02.
Is Shelter Pharma Ltd a good investment?
Bull Run gives Shelter Pharma Ltd a score of 64.5/100. This is not investment advice — consult a SEBI-registered advisor.